32-OR: The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial
Year: 2020
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes
DOI: 10.2337/db20-32-or
Authors: JOHN J.V. MCMURRAY, MASON W. FREEMAN, JOE MASSARO, SCOTT SOLOMON, PAUL LOCK, MATTHEW C. RIDDLE, ELDRIN LEWIS, YUAN-DI C. HALVORSEN
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3034405170